Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06387485 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
A NA study of Osteosarcoma and Chondrosarcoma, sponsored by Ricoh USA.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 3
- Study locations
NCT06387485 is a NA study of Osteosarcoma and Chondrosarcoma that is actively recruiting participants, run by Ricoh USA. The registered enrollment target is 150 participants, below the 299-participant average among 46 other Osteosarcoma trials with a reported enrollment target (50% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06387485, a NA study of Osteosarcoma and Chondrosarcoma, is actively recruiting participants, sponsored by Ricoh USA.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 3
- Study locations
Study Summary
This prospective, multi-center, randomized controlled study aims to assess the efficacy of utilizing 3D printed models in preoperative planning for the excision of tumors involving bony structures within the body. The study is expected to last approximately 12 months and involve up to 150 subjects across up to 5 sites. Subjects will be randomized in a 1:1 ratio into either the experimental arm, utilizing 3D printed models and imaging, or the active comparator arm, using only imaging. Primary endpoint: Operative time of surgical procedure. Secondary endpoints: Reduction of blood loss, proportion of postoperative adverse events, and negative tumor margins. Exploratory endpoints: Surgical planning ease, changes in surgical plan, and surgeon satisfaction.
Conditions Studied
Interventions
- DEVICE 3D Printed Anatomic Model
- DIAGNOSTIC_TEST CT/MRI
Study Locations (3)
California
- Kaiser Permanente Oakland Medical Center - Oakland
Michigan
- William Beaumont University Hospital - Royal Oak
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06387485
The ClinicalTrials.gov registry entry for NCT06387485 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 299-participant average among 46 other Osteosarcoma trials with a reported enrollment target (50% lower). The listed sponsor is Ricoh USA, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Osteosarcoma appearing as the primary indexed condition, and to 2 interventions - of which 3D Printed Anatomic Model is the first listed.
NCT06387485 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Michigan, Ohio.
Frequently Asked Questions
What is clinical trial NCT06387485 about?
NCT06387485 is a clinical study titled "A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning". This prospective, multi-center, randomized controlled study aims to assess the efficacy of utilizing 3D printed models in preoperative planning for the excision of tumors involving bony structures within the body. The study is expected to last approximately 12 months and involve up to 150 subjects a...
What is the current status of trial NCT06387485?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-03-01. Estimated completion is 2027-07-31.
What conditions does trial NCT06387485 study?
This clinical trial studies the following conditions: Osteosarcoma, Chondrosarcoma, Sarcoma, Ewing, Fibrosarcoma, Fibrous Histiocytoma.
What interventions are being tested in trial NCT06387485?
The interventions under investigation include: 3D Printed Anatomic Model (DEVICE), CT/MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06387485?
This trial is sponsored by Ricoh USA, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06387485 being conducted?
This trial has 3 study locations across California, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteosarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Musculoskeletal Cancers Remote Monitoring and Care
RECRUITING · NA
-
Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors
ACTIVE NOT RECRUITING · NA
-
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RECRUITING · Phase 1
-
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
RECRUITING · Phase 1
-
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
RECRUITING · Phase 1
-
Losartan + Sunitinib in Treatment of Osteosarcoma
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.